Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Loidl

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Der Urologe. Ausg. A|October 11, 2018
[Immunotherapy for locally advanced and metastasized bladder cancer]W Loidl, F Luger
Der Urologe. Ausg. A|March 12, 2014
[Castration-resistant prostate cancer (CRPC)]W Loidl, F Luger, A Roosen
European Urology|February 18, 2005
Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?W Loidl, J Schmidbauer, M Susani, et al.
The Journal of Urology|January 1, 1987
Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?G Jakse, W Loidl, G Seeber, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 17, 2012
Imaging of bone metastases in prostate cancer: an updateW Langsteger, S Haim, M Knauer, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 9, 2011
Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked readingW Langsteger, S Balogova, V Huchet, et al.
Prostate Cancer and Prostatic Diseases|January 27, 2016
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomyS Sevcenco, R Mathieu, P Baltzer, et al.
Prostate Cancer and Prostatic Diseases|September 4, 2013
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomyM Rieken, L A Kluth, E Xylinas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2025
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 studyC Gratzke, M Özgüroğlu, A Peer, et al.
British Journal of Cancer|July 9, 2014
Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessmentL A Kluth, F Abdollah, E Xylinas, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Der Urologe. Ausg. A|October 11, 2018
[Immunotherapy for locally advanced and metastasized bladder cancer]W Loidl, F Luger
Der Urologe. Ausg. A|March 12, 2014
[Castration-resistant prostate cancer (CRPC)]W Loidl, F Luger, A Roosen
European Urology|February 18, 2005
Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?W Loidl, J Schmidbauer, M Susani, et al.
The Journal of Urology|January 1, 1987
Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?G Jakse, W Loidl, G Seeber, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 17, 2012
Imaging of bone metastases in prostate cancer: an updateW Langsteger, S Haim, M Knauer, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 9, 2011
Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked readingW Langsteger, S Balogova, V Huchet, et al.
Prostate Cancer and Prostatic Diseases|January 27, 2016
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomyS Sevcenco, R Mathieu, P Baltzer, et al.
Prostate Cancer and Prostatic Diseases|September 4, 2013
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomyM Rieken, L A Kluth, E Xylinas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2025
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 studyC Gratzke, M Özgüroğlu, A Peer, et al.
British Journal of Cancer|July 9, 2014
Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessmentL A Kluth, F Abdollah, E Xylinas, et al.
Pageof 2